Clinical Trial Update: Predicting Response to Incretin Based Agents in Type 2 Diabetes

View source ↗

Summary

This completed clinical trial studied predictors of response to incretin-based therapies in individuals with Type 2 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Snippet

Sponsor: Royal Devon and Exeter NHS Foundation Trust | Conditions: Type2 Diabetes | Status: COMPLETED